Precision

Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on Genome Editing Research

  • by

Shots: Precision to receive $100M upfront, $35M as an equity investment and will receive $420M as milestones/ product along with royalties on sales of licensed products emerges from the collaboration Precision will lead to pre-clinical research and IND-enabling activities while Lilly will lead clinical development… Read More »Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on Genome Editing Research

Using HEOR Methods to Reduce Health Inequalities

  • by

Join me tomorrow, 9/26, 12:00 PM EDT, as PRECISIONheor’s Jason Shafrin and Meena Venkatachalam discuss their recent blog commentary in the health policy journal Health Affairs on how novel methods of Cost-Effectiveness Analysis can be used to expand traditional value frameworks improve health outcomes for underserved communities. Moderated by Precision’s Kelly… Read More »Using HEOR Methods to Reduce Health Inequalities